Cargando…
BTK and PI3K Inhibitors Reveal Synergistic Inhibitory Anti-Tumoral Effects in Canine Diffuse Large B-Cell Lymphoma Cells
Bruton’s tyrosine kinase (BTK) and phosphoinositide 3-kinase (PI3K) in the B-cell receptor (BCR) signaling pathway are considered potential therapeutic targets for the treatment of B-cell lymphomas, among which, diffuse large B-cell lymphoma (DLBCL) is the most common type. Herein, we comparatively...
Autores principales: | Kong, Weibo, Sender, Sina, Taher, Leila, Villa-Perez, Simon, Ma, Yixuan, Sekora, Anett, Ruetgen, Barbara C., Brenig, Bertram, Beck, Julia, Schuetz, Ekkehard, Junghanss, Christian, Nolte, Ingo, Murua Escobar, Hugo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658042/ https://www.ncbi.nlm.nih.gov/pubmed/34884478 http://dx.doi.org/10.3390/ijms222312673 |
Ejemplares similares
-
Establishment and characterization of stable red, far-red (fR) and near infra-red (NIR) transfected canine prostate cancer cell lines
por: Liu, Wen, et al.
Publicado: (2020) -
Evaluation of the Synergistic Potential of Simultaneous Pan- or Isoform-Specific BET and SYK Inhibition in B-Cell Lymphoma: An In Vitro Approach
por: Sender, Sina, et al.
Publicado: (2022) -
RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures
por: Packeiser, Eva-Maria, et al.
Publicado: (2022) -
Characterization of the novel indolylmaleimides' PDA-66 and PDA-377 effect on canine lymphoma cells
por: Liu, Wen, et al.
Publicado: (2016) -
Precursor B-ALL Cell Lines Differentially Respond to SYK Inhibition by Entospletinib
por: Sender, Sina, et al.
Publicado: (2021)